
Saptrax SB 250mg/125mg Injection
Marketer
Sapson Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Saptrax SB 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats diverse bacterial infections. This medication inhibits microbial proliferation, halting infection progression. Administration requires strict oversight by a healthcare provider; adhere diligently to the prescribed schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medication's effects.
Primary Ingredients of Saptrax SB 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Saptrax SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Saptrax SB 250mg/125mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Saptrax SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Saptrax SB 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Saptrax SB 250mg/125mg Injection works:
Ceftriaxone 250mg/Sulbactam 125mg Injection (Saptrax SB) combines a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Sulbactam. Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam's role is to counter bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Saptrax SB 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Saptrax SB 250mg/125mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or absent negative impacts on fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Saptrax SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The Saptrax SB 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Saptrax SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The use of Saptrax SB 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Patients should seek medical advice. Dosage alteration for Saptrax SB 250mg/125mg Injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Saptrax SB 250mg/125mg Injection :
Should you inadvertently skip a dose of Saptrax SB 250mg/125mg Injection, seek your physician's advice.
Facts to Know About Saptrax SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
